Format
Sort by

Send to

Choose Destination

Search results

Items: 14

1.

Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival.

Eilertsen M, Andersen S, Al-Saad S, Kiselev Y, Donnem T, Stenvold H, Pettersen I, Al-Shibli K, Richardsen E, Busund LT, Bremnes RM.

PLoS One. 2014 Sep 16;9(9):e105038. doi: 10.1371/journal.pone.0105038. eCollection 2014.

2.

Stage and tissue-specific prognostic impact of miR-182 in NSCLC.

Stenvold H, Donnem T, Andersen S, Al-Saad S, Busund LT, Bremnes RM.

BMC Cancer. 2014 Feb 27;14:138. doi: 10.1186/1471-2407-14-138.

3.

High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome.

Stenvold H, Donnem T, Andersen S, Al-Saad S, Valkov A, Pedersen MI, Busund LT, Bremnes RM.

BMC Clin Pathol. 2014 Feb 13;14(1):9. doi: 10.1186/1472-6890-14-9.

4.

Positive prognostic impact of miR-210 in non-small cell lung cancer.

Eilertsen M, Andersen S, Al-Saad S, Richardsen E, Stenvold H, Hald SM, Al-Shibli K, Donnem T, Busund LT, Bremnes RM.

Lung Cancer. 2014 Feb;83(2):272-8. doi: 10.1016/j.lungcan.2013.11.005. Epub 2013 Nov 14.

PMID:
24305009
5.

CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy.

Hald SM, Bremnes RM, Al-Shibli K, Al-Saad S, Andersen S, Stenvold H, Busund LT, Donnem T.

Lung Cancer. 2013 May;80(2):209-15. doi: 10.1016/j.lungcan.2012.12.026. Epub 2013 Feb 4.

PMID:
23384671
6.

MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer.

Donnem T, Fenton CG, Lonvik K, Berg T, Eklo K, Andersen S, Stenvold H, Al-Shibli K, Al-Saad S, Bremnes RM, Busund LT.

PLoS One. 2012;7(1):e29671. doi: 10.1371/journal.pone.0029671. Epub 2012 Jan 25.

7.

Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival.

Andersen S, Donnem T, Stenvold H, Al-Saad S, Al-Shibli K, Busund LT, Bremnes RM.

PLoS One. 2011;6(8):e23847. doi: 10.1371/journal.pone.0023847. Epub 2011 Aug 22.

8.

Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcome.

Stenvold H, Donnem T, Andersen S, Al-Saad S, Al-Shibli K, Busund LT, Bremnes RM.

Lung Cancer. 2012 Feb;75(2):235-41. doi: 10.1016/j.lungcan.2011.06.010. Epub 2011 Jul 18.

PMID:
21764478
9.

Correlation and coexpression of HIFs and NOTCH markers in NSCLC.

Andersen S, Donnem T, Al-Saad S, Al-Shibli K, Stenvold H, Busund LT, Bremnes RM.

Anticancer Res. 2011 May;31(5):1603-6.

PMID:
21617216
10.

Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2.

Andersen S, Donnem T, Al-Shibli K, Al-Saad S, Stenvold H, Busund LT, Bremnes RM.

PLoS One. 2011;6(5):e19773. doi: 10.1371/journal.pone.0019773. Epub 2011 May 16.

11.

Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival.

Donnem T, Lonvik K, Eklo K, Berg T, Sorbye SW, Al-Shibli K, Al-Saad S, Andersen S, Stenvold H, Bremnes RM, Busund LT.

Cancer. 2011 Jul 15;117(14):3193-200. doi: 10.1002/cncr.25907. Epub 2011 Jan 24.

12.

Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization.

Donnem T, Eklo K, Berg T, Sorbye SW, Lonvik K, Al-Saad S, Al-Shibli K, Andersen S, Stenvold H, Bremnes RM, Busund LT.

J Transl Med. 2011 Jan 10;9:6. doi: 10.1186/1479-5876-9-6.

13.

The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer.

Bremnes RM, Al-Shibli K, Donnem T, Sirera R, Al-Saad S, Andersen S, Stenvold H, Camps C, Busund LT.

J Thorac Oncol. 2011 Apr;6(4):824-33. doi: 10.1097/JTO.0b013e3182037b76. Review.

14.
Items per page

Supplemental Content

Loading ...
Write to the Help Desk